Latest News about Briefs
Recent news which mentions Briefs
HealthEquity Earns Stock Upgrade Despite Fraud Concerns
March 25, 2025
From Benzinga
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
March 25, 2025
From Benzinga
From Benzinga
From Benzinga
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
March 25, 2025
From Benzinga
23andMe's Bankruptcy Sparks Privacy Concerns Over Genetic Database Of 15 Million Customers
March 25, 2025
From Benzinga
From Benzinga
MicroVision's Strategic Moves And New CTO Drive Analyst Confidence, But Challenges Remain In Q4
March 25, 2025
From Benzinga
What's In Store For Comcast This Earnings Season? Analyst Predicts New Pricing Strategies Amid Competitive Pressures
March 25, 2025
From Benzinga
Waystar's Modest FY25 Outlook Faces Growth Challenges: Goldman Sachs Analyst Weighs In
March 25, 2025
From Benzinga
From Benzinga
Merck Partners With Hengrui Pharma In $1.77 Billion Deal For Cardiovascular Treatment
March 25, 2025
From Benzinga
From Benzinga
From Benzinga
Beauty At Your Doorstep: Uber Eats Joins Forces With Sally Beauty For On-Demand Product Delivery
March 25, 2025
From Benzinga
Why Is CrowdStrike Stock Gaining Today?
March 25, 2025
From Benzinga
Axsome Therapeutics Lower Dose Of Attention Deficient Disorder Candidate Hits Primary Goal
March 25, 2025
From Benzinga
Mobileye Stock Surges On Volkswagen Partnership To Advance Vehicle Automation: Details
March 25, 2025
From Benzinga
Broadcom Innovates with New Sian3 and Sian2M DSPs, Cutting Power for Scalable AI/ML Connectivity
March 25, 2025
From Benzinga
Cognizant Boosts Stock Buyback, Partners With NVIDIA To Enhance Enterprise Operations With Neuro AI Platform
March 25, 2025
From Benzinga
What's Going On With ViaSat Stock Today?
March 25, 2025
From Benzinga
EVgo, Pilot, GM Reach Milestone With Over 130 Fast-Charging Stations For Long-Distance EV Travel
March 25, 2025
From Benzinga
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
March 25, 2025
From Benzinga
Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug Candidate
March 25, 2025
From Benzinga
China's DeepSeek Ups The Heat In OpenAI Rivalry, Upgrades V3 Model Improving Coding And Reasoning Capability
March 25, 2025
From Benzinga
What's Going On With Rumble Stock Today?
March 25, 2025
From Benzinga
Beam Global Taps MENA Market With Solvana Partnership
March 25, 2025
From Benzinga
United Airlines Unveils Houston Expansion: New Maintenance Facility And Training Center In The Works
March 25, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.